Author:
Wang Yulong,Dong Haiyan,Wu Hongyan,Zhang Li,Yuan Kai,Chen Hongqiang,Jiao Mingwen,Fu Rongzhan
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference33 articles.
1. Brenin D, Morrow M. Conventional axillary dissection: extent, local control, and morbidity. Seninars in breast diseases. 1998;1:118–24.
2. Goyal A, Newcombe RG, Chhabra A, Mansel RE, Group AT. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer–results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006;99:203–8.
3. White Jr RL, Wilke LG. Update on the NSABP and ACOSOG breast cancer sentinel node trials. Am Surg. 2004;70:420–4.
4. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T. National Surgical Adjuvant B, Bowel P. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8:881–8.
5. Cools-Lartigue J, Meterissian S. Accuracy of axillary ultrasound in the diagnosis of nodal metastasis in invasive breast cancer: a review. World J Surg. 2012;36:46–54.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献